首页 News 正文

On August 23rd local time, Moderna, a US biopharmaceutical company, announced that the European Commission (EC) has approved the mRNA respiratory syncytial virus (RSV) vaccine mRESVIA& reg; (mRNA-1345) has been launched, and this vaccine is used to protect adults aged 60 and above from respiratory diseases caused by RSV infection.
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

王俊杰2017 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    28